SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
58 hedge funds and large institutions have $87.2M invested in Strongbridge Biopharma plc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $135M → $87.2M (-$48M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holding in Top 10
1
Calls
$8K
Puts
$2K
Top Buyers
| 1 | +$5.32M | |
| 2 | +$5.05M | |
| 3 | +$1.52M | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$1.25M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$814K |
Top Sellers
| 1 | -$4.74M | |
| 2 | -$4.55M | |
| 3 | -$3.9M | |
| 4 |
AC
Armistice Capital
New York
|
-$2.85M |
| 5 |
BC
Broadfin Capital
New York
|
-$774K |